SCHEMBL7684227

SCHEMBL7684227

Cc1ccc(=O)n(CCN2CCNCC2c2cccc3ccccc23)n1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
HTR2C P28335 5/20 0.36
HTR2A P28223 4/20 0.36
ATM Q13315 1/20 0.35
HTR2B P41595 2/20 0.35
PKM P14618 1/20 0.35
KCNH2 Q12809 1/20 0.35
IDE P14735 1/20 0.34
UBE2N P61088 1/20 0.34
DRD2 P14416 1/20 0.34
SLC6A4 P31645 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTR6 P50406 1/20 0.33
MTNR1A P48039 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681583 0.94 TAAR1 (0.40) TDP1TAAR1HTR2CHTR2AATM
SCHEMBL7681450 0.94 TAAR1 (0.40) TDP1TAAR1HTR2CHTR2AATM
SCHEMBL7681402 0.86 CREBBP (0.44) PKMALDH1A1
SCHEMBL7681468 0.81 CREBBP (0.42) TAAR1PKM
SCHEMBL7679337 0.81 CREBBP (0.42) TAAR1PKM
SCHEMBL8597121 0.80 NPC1 (0.43) TDP1TAAR1HTR2CHTR2AATM
SCHEMBL8594653 0.74 HTR2A (0.39) TDP1TAAR1HTR2CHTR2AHTR2B
SCHEMBL8595853 0.74 NPC1 (0.42) TDP1TAAR1HTR2CHTR2AATM
SCHEMBL8598453 0.74 NPC1 (0.42) TDP1TAAR1HTR2CHTR2AATM
SCHEMBL6164922 0.73 HTR2A (0.45) TDP1TAAR1HTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413966-B1 SEROTONERGIC AND CENTRAL DOPAMINERGIC ACTIVITY; AFFINITY FOR 5HT1A AND 5HT2 SEROTONIN AND D2 DOPAMINE RECEPTORS; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. 2002-07-02 US claimed
EP-1057820-A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) 2000-12-06 EP claimed